Trial Profile
Randomized Multicenter Placebo-controlled Trial on the Effect of Adalumumab on Vascular Inflammation in Patient With Moderate to Severe Psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Atherosclerosis; Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Innovaderm Research
- 22 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 27 Mar 2015 Planned End Date changed from 1 Feb 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov record.
- 27 Mar 2015 Planned primary completion date changed from 1 Nov 2014 to 1 Nov 2015 as reported by ClinicalTrials.gov record.